Assignment: Women and Men Health, Infectious Disease, and Hematologic Disorders
Assignment: Women and Men Health, Infectious Disease, and Hematologic Disorders
As an advanced practice nurse, you will likely experience patient encounters with complex comorbidities. For example, consider a female patient who is pregnant who also presents with hypertension, diabetes, and has a recent tuberculosis infection. How might the underlying pathophysiology of these conditions affect the pharmacotherapeutics you might recommend to help address your patient’s health needs? What education strategies might you recommend for ensuring positive patient health outcomes?
ORDER A PLAGIARISM FREE PAPER HERE ON ;Assignment: Women and Men Health, Infectious Disease, and Hematologic Disorders
Thanks for stopping by this assessment. We can assist you in completing it and other subsequent ones. Our expert writers will comprehensively review instructions, synthesize external evidence sources, and customize an A-grade paper. Kindly scroll down to review the sample.
For this Discussion, you will be assigned a patient case study and will consider how to address the patient’s current drug therapy plans. You will then suggest recommendations on how to revise these drug therapy plans to ensure effective, safe, and quality patient care for positive patient health outcomes.
Post a brief description of your patient’s health needs from the patient case study you assigned. Be specific. Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice or pharmacotherapeutics you would recommend and explain why. Be sure to justify your response. Explain a patient education strategy you might recommend for assisting your patient with the management of their health needs. Be specific and provide examples.
[elementor-template id="144964"]Case Study:
A 46-year-old, 230lb woman with a family history of breast cancer. She is up to date on yearly mammograms. She has a history of HTN. She complains of hot flushing, night sweats, and genitourinary symptoms. She had felt well until 1 month ago and she presented to her gynecologist for her annual gyn examination and to discuss her symptoms. She has a history of ASCUS about 5 years ago on her pap, other than that, Pap smears have been normal. Home medications are Norvasc 10mg qd and HCTZ 25mg qd. Her BP today is 150/90. She has regular monthly menstrual cycles. Her LMP was 1 month ago.
Assignment: Women and Men Health, Infectious Disease, and Hematologic Disorders
The patient in the case study is a 46-year-old female with a family history of breast cancer. She currently weighs 230lb and has a history of HTN. She reports having hot flushes, night sweats, and genitourinary symptoms for the past month. The identified patient’s health needs include perimenopausal vasomotor symptoms like hot flushes, night sweats, and genitourinary symptoms. The patient is obese, which increases her risk of developing lifestyle diseases like diabetes, dyslipidemia, and various cancers (Ansari et al., 2020). In addition, the patient’s systolic BP is elevated at 150 mmHg, and her history of HTN puts her at risk of complications like stroke, heart failure, and kidney failure. Furthermore, given her history of ASCUS and family history of breast cancer, she has a high risk for cervical and breast cancer.
BUY A CUSTOM FREE PAPER HERE ON ;Assignment: Women and Men Health, Infectious Disease, and Hematologic Disorders
The recommended treatment regimen for this patient is the combined Hormone replacement therapy (HRT) comprising estrogen and progesterone. HRT is considered the most effective therapy for perimenopausal vasomotor symptoms. Pan et al. (2022) assert that estrogen therapy is the most effective treatment for alleviating hot flashes. Transdermal administration of estrogen is recommended to avoid the hepatic first-pass effect and reduce the risk of venous thromboembolism. Combining estrogen with progestin is recommended to protect the endometrium for women with an intact uterus, which prevents carcinoma and endometrial hyperplasia (Palacios et al., 2019).
The patient education strategy that can be applied to this patient includes providing her with educational materials in her preferred formats. Consequently, I will need to assess her preferred learning strategy, visual, aural, read/write, or kinesthetic (Bhattad & Pacifico, 2022). If the patient’s learning style is visual, I will use charts, graphics, posters, charts, and PowerPoint presentations to provide patient education. If she is a kinesthetic learner, I would use demonstrations.
References
Ansari, S., Haboubi, H., & Haboubi, N. (2020). Adult obesity complications: challenges and clinical impact. Therapeutic advances in endocrinology and metabolism, 11, 2042018820934955. https://doi.org/10.1177/2042018820934955
Bhattad, P. B., & Pacifico, L. (2022). Empowering Patients: Promoting Patient Education and Health Literacy. Cureus, 14(7), e27336. https://doi.org/10.7759/cureus.27336
Palacios, S., Stevenson, J. C., Schaudig, K., Lukasiewicz, M., & Graziottin, A. (2019). Hormone therapy for first-line management of menopausal symptoms: Practical recommendations. Women’s health (London, England), 15, 1745506519864009. https://doi.org/10.1177/1745506519864009
Pan, M., Pan, X., Zhou, J., Wang, J., Qi, Q., & Wang, L. (2022). Update on hormone therapy for the management of postmenopausal women. Bioscience trends, 16(1), 46–57. https://doi.org/10.5582/bst.2021.01418
[elementor-template id="144964"]